Dolix Medical Diagnostic Products LLC is categorized under Medical Labs in Webster, TX and active since 2011.
Dolix Medical Diagnostic Products LLC was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Gopal Savjani at the company’s single location by writing to 445 West Medical Center Boulevard, Webster, Texas TX 77598 or by phoning (281) 404-0263. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Dolix Medical Diagnostic Products LLC |
Contact Person: | Gopal Savjani |
Address: | 445 West Medical Center Boulevard, Webster, Texas 77598 |
Phone Number: | (281) 404-0263 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Labs |
SIC Code: | 8071 |
NAICS Code: | 621511 |
Share This Business: |
Dolix Medical Diagnostic Products LLC was started in 2011 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Gopal Savjani for inquiries that concern Dolix Medical Diagnostic Products LLC by calling the company number (281) 404-0263, as your correspondence is most welcome. Additionally, the physical location of the single location of Dolix Medical Diagnostic Products LLC can be found at the coordinates 29.538658,-95.129487 as well as the street address 445 West Medical Center Boulevard in Webster, Texas 77598.
For its online presence, you may visit Dolix Medical Diagnostic Products LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.